Suppr超能文献

伊尔斯病中玻璃体血管内皮生长因子与色素上皮衍生因子的比值

Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease.

作者信息

Angayarkanni Narayanasamy, Selvi Radhakrishnan, Pukhraj Rishi, Biswas Jyotirmoy, Bhavesh Shah J, Tombran-Tink Joyce

出版信息

J Ocul Biol Dis Infor. 2009 Mar 6;2(1):20-8. doi: 10.1007/s12177-009-9017-7.

Abstract

Eales disease (ED) is an idiopathic inflammatory venous occlusion of the peripheral retina. As neovascularization is prominent in ED, this study attempts to look at the ratio of VEGF, the angiogenic factor, and PEDF, an anti-angiogenic factor in the vitreous of ED patients in comparison with the macular hole (MH) and Proliferative Diabetic Retinopathy (PDR). Vitreous levels of VEGF and PEDF were determined in the undiluted vitreous specimen obtained from 26 ED cases, 17 PDR, and seven patients with MH. The vitreous levels of VEGF and PEDF were estimated by ELISA. The immunohistochemistry (IHC) for VEGF and PEDF were done in the epiretinal membrane of ED and PDR case. The VEGF/PEDF ratio was found to be significantly increased in ED (p = 0.014) and PDR (p = 0.000) compared to MH. However the ratio was 3.5-fold higher in PDR than ED (p = 0.009). The IHC data on the ERM specimen from ED showed the presence of VEGF and PEDF similar to PDR. The high angiogenic potential seen as the ratio of VEGF/PEDF correlates with the peak clinical onset of the disease in the age group 21-30 years and the diseases usually self-resolves above the age of 40, which is reflected by the low ratio of VEGF/PEDF. The study shows that the VEGF/PEDF ratio is significantly increased in ED though the angiogenic potential is higher in PDR than in ED. Clinically Eales Disease is known as a self-limiting disease, while PDR is a progressive disease.

摘要

伊尔斯病(ED)是一种特发性外周视网膜静脉炎性阻塞疾病。由于新生血管形成在伊尔斯病中较为突出,本研究试图观察血管生成因子血管内皮生长因子(VEGF)与抗血管生成因子色素上皮衍生因子(PEDF)在伊尔斯病患者玻璃体中的比例,并与黄斑裂孔(MH)和增殖性糖尿病视网膜病变(PDR)患者进行比较。对26例伊尔斯病患者、17例增殖性糖尿病视网膜病变患者和7例黄斑裂孔患者未稀释的玻璃体标本测定VEGF和PEDF的玻璃体水平。通过酶联免疫吸附测定法(ELISA)评估VEGF和PEDF的玻璃体水平。对伊尔斯病和增殖性糖尿病视网膜病变患者的视网膜前膜进行VEGF和PEDF的免疫组织化学(IHC)检测。结果发现,与黄斑裂孔相比,伊尔斯病(p = 0.014)和增殖性糖尿病视网膜病变(p = 0.000)患者的VEGF/PEDF比例显著升高。然而,增殖性糖尿病视网膜病变患者的该比例比伊尔斯病患者高3.5倍(p = 0.009)。伊尔斯病患者视网膜前膜标本的免疫组织化学数据显示,VEGF和PEDF的存在情况与增殖性糖尿病视网膜病变相似。VEGF/PEDF比例所显示的高血管生成潜力与21 - 30岁年龄组疾病的临床发病高峰相关,且该疾病通常在40岁以上自行缓解,这表现为VEGF/PEDF比例较低。该研究表明,尽管增殖性糖尿病视网膜病变的血管生成潜力高于伊尔斯病,但伊尔斯病患者的VEGF/PEDF比例仍显著升高。临床上,伊尔斯病是一种自限性疾病,而增殖性糖尿病视网膜病变是一种进行性疾病。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验